Shu-Yi Liao
Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoidosis | 4 | 2025 | 154 | 2.450 |
Why?
| Gene-Environment Interaction | 1 | 2023 | 186 | 0.780 |
Why?
| Granuloma | 1 | 2021 | 89 | 0.710 |
Why?
| Genetic Predisposition to Disease | 3 | 2024 | 2282 | 0.710 |
Why?
| Genome-Wide Association Study | 2 | 2024 | 1341 | 0.670 |
Why?
| Graft vs Host Disease | 1 | 2022 | 239 | 0.650 |
Why?
| Asthma | 2 | 2022 | 2265 | 0.590 |
Why?
| Transcriptome | 1 | 2024 | 890 | 0.570 |
Why?
| Adrenal Cortex Hormones | 1 | 2020 | 527 | 0.550 |
Why?
| Sarcoidosis, Pulmonary | 2 | 2025 | 79 | 0.430 |
Why?
| Macrophages | 1 | 2021 | 1482 | 0.430 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 986 | 0.410 |
Why?
| Vaccines, Synthetic | 2 | 2022 | 129 | 0.380 |
Why?
| Antibody Formation | 2 | 2022 | 287 | 0.350 |
Why?
| Lung Neoplasms | 1 | 2022 | 2376 | 0.320 |
Why?
| Antibodies, Viral | 2 | 2022 | 607 | 0.290 |
Why?
| HLA-DR alpha-Chains | 1 | 2023 | 4 | 0.220 |
Why?
| Tomography, X-Ray Computed | 2 | 2025 | 2551 | 0.220 |
Why?
| HLA-DRB1 Chains | 1 | 2023 | 109 | 0.210 |
Why?
| Biological Therapy | 1 | 2022 | 30 | 0.200 |
Why?
| Genetic Association Studies | 1 | 2023 | 359 | 0.190 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2024 | 649 | 0.190 |
Why?
| Humans | 11 | 2025 | 130305 | 0.180 |
Why?
| Leukocytes, Mononuclear | 1 | 2023 | 550 | 0.170 |
Why?
| Alleles | 1 | 2023 | 848 | 0.170 |
Why?
| Image Processing, Computer-Assisted | 1 | 2025 | 745 | 0.170 |
Why?
| Propensity Score | 1 | 2020 | 265 | 0.160 |
Why?
| Administration, Inhalation | 1 | 2020 | 675 | 0.160 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 433 | 0.150 |
Why?
| Genetic Variation | 1 | 2023 | 939 | 0.150 |
Why?
| Early Detection of Cancer | 1 | 2022 | 350 | 0.150 |
Why?
| Odds Ratio | 1 | 2020 | 1027 | 0.150 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2024 | 2074 | 0.130 |
Why?
| Logistic Models | 1 | 2020 | 1980 | 0.120 |
Why?
| Viral Matrix Proteins | 1 | 2015 | 25 | 0.120 |
Why?
| Phenotype | 1 | 2023 | 3084 | 0.120 |
Why?
| Smoking | 1 | 2022 | 1505 | 0.120 |
Why?
| Herpesvirus 4, Human | 1 | 2015 | 154 | 0.110 |
Why?
| Vaccination | 1 | 2022 | 1361 | 0.100 |
Why?
| Neovascularization, Pathologic | 1 | 2015 | 302 | 0.100 |
Why?
| Cohort Studies | 1 | 2020 | 5431 | 0.090 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2015 | 1056 | 0.080 |
Why?
| Female | 4 | 2025 | 68842 | 0.070 |
Why?
| Middle Aged | 3 | 2025 | 31322 | 0.070 |
Why?
| Risk Factors | 1 | 2020 | 9865 | 0.070 |
Why?
| Adult | 3 | 2024 | 35711 | 0.060 |
Why?
| Male | 5 | 2025 | 63748 | 0.060 |
Why?
| Disease Progression | 2 | 2024 | 2639 | 0.050 |
Why?
| Aged | 1 | 2020 | 22282 | 0.050 |
Why?
| Fever | 1 | 2022 | 303 | 0.040 |
Why?
| Neoplasms | 1 | 2015 | 2467 | 0.040 |
Why?
| DNA Methylation | 1 | 2024 | 610 | 0.040 |
Why?
| MicroRNAs | 1 | 2024 | 680 | 0.040 |
Why?
| RNA, Messenger | 1 | 2024 | 2732 | 0.030 |
Why?
| Case-Control Studies | 1 | 2024 | 3369 | 0.030 |
Why?
| Referral and Consultation | 1 | 2022 | 736 | 0.030 |
Why?
| Epitopes, T-Lymphocyte | 1 | 2015 | 185 | 0.030 |
Why?
| Lung | 1 | 2025 | 3967 | 0.020 |
Why?
| Dendritic Cells | 1 | 2015 | 484 | 0.020 |
Why?
| Lymphocyte Activation | 1 | 2015 | 1101 | 0.020 |
Why?
| Peptide Fragments | 1 | 2015 | 698 | 0.020 |
Why?
| Mice, Knockout | 1 | 2015 | 2811 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2015 | 3185 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2015 | 4044 | 0.010 |
Why?
| Retrospective Studies | 1 | 2022 | 14675 | 0.010 |
Why?
| Mice | 1 | 2015 | 16832 | 0.010 |
Why?
| Animals | 1 | 2015 | 35076 | 0.010 |
Why?
|
|
Liao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|